A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial Nature Nawigacja wpisu Former Michigan Medicine dean omitted multimillion-dollar pharma ties in multiple publications, Daily investigation finds – The Michigan Daily Penn Medicine’s top lawyer set to retire this June – The Daily Pennsylvanian
